Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines

Fig. 1

The historical development of pseudomyxoma peritonei (PMP) management and consensuses and controversies among different clinical recommendations worldwide. Consensus, black frame; Controversy, red frame. PSOGI, Peritoneal Surface Oncology Group International; EURACAN, European Rare Cancer; PMP, pseudomyxoma peritonei; MTD, maximal tumor debulking; HIPEC, hyperthermic intraperitoneal chemotherapy; CC, completeness of cytoreduction; EPIC, early postoperative intraperitoneal chemotherapy; CRS, cytoreductive surgery

Back to article page